What Tobinco Pharmaceuticals does

Tobinco Pharmaceuticals Limited (TPL) is a privately held pharmaceutical marketing and distribution company headquartered in Accra, Ghana, founded in 1994. The company distributes a portfolio of generic pharmaceuticals, antibiotics, antimalarials, analgesics, food supplements, dermatologicals, gastro-intestinal products, and anti-hypertensives through 16 branches across 13 regions of Ghana, supported by six regional sector offices (Northern, Southern, Western, Volta, Brong Ahafo, Upper) and nine wholesale divisions (Okaishie, Odorkor, Spintex, Lapaz, Kotobabi, Asamankese, Nkawkaw, Koforidua, Swedru). Its sister company, Entrance Pharmaceuticals and Research Centre, provides backward integration into manufacturing for proprietary brands such as Lufart, Tobcee, Funbact-A, and Entramol.

The company serves pharmacies, hospitals, clinics, and healthcare facilities as its primary B2B customer segment, with consumer end-patients as a secondary downstream channel. Operations are GMP and ISO 9001 certified, and Tobinco self-describes as Ghana's leading pharmaceutical marketing and distribution company. Distribution has expanded beyond Ghana to most West African countries. The company holds Ghana Club 100 recognition (No. 48, 2019), Pharmaceutical Company of the Year (2022), and multiple industry awards for product brands including Lonart (CIMG Product of the Year, 2014) and Alaxin.

Tobinco's revenue model combines wholesale pharmaceutical distribution margins with proprietary product sales from its manufacturing arm. Pricing is B2B and not publicly disclosed. The company is family-controlled under Group Chairman Samuel Amo Tobbin, with Executive Director Araba Sika Tobbin and Managing Director Andrew John Ofori leading operations. In July 2024, the High Court in Accra cleared Tobinco of all allegations of importing fake drugs, resolving a decade-long dispute with the Ghana FDA.

Name

Tobinco Pharmaceuticals

Legal name

Tobinco Pharmaceuticals Limited

Website

https://tobincopharma.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Tobinco Pharmaceuticals Limited is Ghana's leading pharmaceutical marketing and distribution company, operating 16 branches and 9 wholesale divisions across 13 regions, distributing generic and proprietary pharmaceuticals to pharmacies and hospitals with expansion into West Africa.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)

akta.pro secondary industries

OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC), First Aid & Wound Care (HLAIADAM)

Keywords

• Pharmaceutical distribution
• Generic medications
• Pharmaceutical manufacturing
• Antimalarial medicines
• Pharmaceutical marketing

Headquarters

HQ city

Accra

HQ country

Ghana

HQ region

Africa

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Pharmaceutical Distribution: Wholesale and retail distribution of pharmaceutical products including generic medications, antibiotics, antimalarials, analgesics, food supplements, and medical devices
2. Product Sales: Sale of proprietary pharmaceutical products manufactured through sister company Entrance Pharmaceuticals and Research Centre

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Tobinco Pharmaceuticals Limited is a pharmaceutical marketing and distribution company that supplies generic pharmaceuticals, over-the-counter medicines, food supplements, dermatologicals, and medical devices to pharmacies, hospitals, clinics, and wholesale buyers across Ghana and West Africa. Its portfolio spans antibiotics, antimalarials, analgesics, cough and cold remedies, hematinics, gastro-intestinal, and anti-diabetic/anti-hypertensive products, with proprietary manufacturing conducted through its sister company, Entrance Pharmaceuticals and Research Centre, under GMP and ISO 9001 standards.

Product overview

Tobinco Pharmaceuticals Limited (TPL) is Ghana's leading pharmaceutical marketing and distribution company, operating 16 branches across 13 regions with expansion into West Africa. The company offers a diverse portfolio of generic pharmaceuticals and health products organized into eight main categories: Antibiotics (including Amovulin, Amurox, Azirocin, X'Mox, X'Flux, Clindamycin), Anti-Malarials (Lufart, Artenate, SP-DOX), Analgesics (Blopen, Entramol, Co-Entramol, Entradol, Lyten Forte), Cough & Cold Products (Kofof, Cold Rilif, Entralyn, Mucotin), Food Supplements & Hematinics (Tobcee, Tobvital, X'Feron, Zinvite, Foligrow, Neuro-Min Plus, Alvite), Dermatological Products (Funbact-A, Combat-N, Entrima Cream, Omal Antiseptic), Gastro Intestinal Products (Ancigel, Entrance Liver Salt, Mepacid), and Anti Diabetic & Anti Hypertensive medications (Nifin, Amlocad, Atenolol, Lisinopril). The company has backwardly integrated into producing its own pharmaceutical products through its sister company, Entrance Pharmaceuticals and Research Centre.

Differentiator

Problem solved

Functional benefit

Products and services

• Antibiotics portfolio (Amovulin, X'Mox, Azirocin, X'Flux, Entracin, Doxycil, Amurox, Ciprofloxacin, X'Zole) A range of branded generic antibiotic formulations including amoxicillin/clavulanate, azithromycin, cefuroxime, clindamycin, doxycycline, flucloxacillin, ciprofloxacin, and metronidazole in capsules, tablets, and suspensions for treating bacterial infections in adults and children. Sold to pharmacies, hospitals, and clinics across Ghana and West Africa.
• Anti-malarial portfolio (Lufart, Lufart DS/Forte, Artenate, SP-DOX) Artemether/Lumefantrine combination antimalarials in tablet and suspension forms, artesunate injections for severe malaria in 30mg/60mg/120mg strengths, and sulfadoxine/pyrimethamine for malaria prevention and treatment. Distributed for retail pharmacy and institutional use.
• Analgesics portfolio (Blopen, Entramol, Co-Entramol, Entradol, Enpain, Lyten Forte) Generic analgesic formulations including diclofenac (tablet, gel, suppository), paracetamol (tablet, suppository, infusion), paracetamol/codeine combinations, tramadol, aspirin/caffeine combinations, and Lyten Forte for pain and fever management in retail and institutional channels.
• Cough & Cold portfolio (Kofof, Cold Rilif, Entralyn/Plus/Baby, Mucotin, Ozine) Cough suppressants, expectorants, mucolytics, antihistamines, and decongestant combinations marketed in pediatric and adult formulations for treating cough, cold, flu, and allergy symptoms in retail pharmacy channels.
• Food Supplements & Hematinics portfolio (Alvite, Tobcee/Tobcee Forte, Tobvital, X'Feron, Zinvite, Foligrow, Neuro-Min Plus) Vitamin and mineral supplements including multivitamins, vitamin C/zinc immune support, iron and vitamin B12 hematinics, ferrous fumarate tonics, and B-vitamin/glutamic acid nervous-system support products in tablet, capsule, and syrup forms.
• Dermatological portfolio (Funbact-A, Combat-N, Entrima Cream, Omal Antiseptic) Topical dermatological products including a neomycin/betamethasone/clotrimazole triple-action cream, topical antibiotic/anti-inflammatory cream, clotrimazole 1% antifungal cream, and antiseptic hand sanitizer for skin infection and hygiene indications.
• Gastro-Intestinal portfolio (Ancigel, Entrance Liver Salt, Mepacid 20) Antacid gel for acid reflux and indigestion, digestive salts in plain and orange flavors for relief of indigestion and constipation, and omeprazole 20mg tablets for gastric ulcers and acid reflux management.
• Anti-Diabetic & Anti-Hypertensive portfolio (Nifin, Amlocad, Atenolol, Lisinopril) Generic cardiovascular medicines including nifedipine 20mg, amlodipine 5mg/10mg, atenolol 50mg/100mg, and lisinopril 5mg/10mg for management of hypertension and related heart conditions through prescription pharmacy and institutional channels.

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Entrance Pharmaceuticals and Research CentrecoreStrategic or Co-development PartnerSister company of Tobinco Pharmaceuticals handling backward integration into manufacturing. Entrance Pharmaceuticals produces pharmaceutical products for Tobinco's distribution network

Scale indicators6 records

Recent moves8 records

Expansion highlights4 records

Direct peers

• Fidson Healthcare Plc: Nigeria-listed pharmaceutical manufacturer and distributor with a comparable portfolio of generics across antibiotics, antimalarials, and cardiovascular drugs, and a similar strategy of backward-integrated manufacturing feeding a regional distribution network. Closest African peer in scale and model to Tobinco.
• May & Baker Nigeria Plc: Nigeria-listed pharmaceutical manufacturer and distributor with similar therapeutic breadth (antibiotics, antimalarials, analgesics) and West African distribution footprint; directly comparable in business model and target markets.
• Emzor Pharmaceutical Industries Limited: Nigeria-based pharmaceutical manufacturer and distributor with a broad generics portfolio (including flagship Emzor Paracetamol) and pan-Nigeria/regional distribution, making it a directly comparable West African peer in therapeutic categories and customer base.

Broad incumbents

• Sandoz (Novartis division): Global generics leader under Novartis supplying antibiotics, antimalarials and chronic-disease medicines into West Africa through similar pharmacy and hospital channels; competes directly with Tobinco's generic portfolio at larger scale.
• Aspen Pharmacare Holdings Limited: Africa's largest pharmaceutical manufacturer with pan-African commercial reach in generics, anti-infectives and consumer health; a regional incumbent whose branded generics directly contest Tobinco's product lines in West African tenders and retail pharmacy.
• GlaxoSmithKline / Haleon (Ghana operations): Multinational consumer health and pharmaceutical major with established Ghana presence across analgesics, vitamins and wellness products; overlaps with Tobinco's OTC and food supplement lines but operates from a global brand and capital base.
• Sanofi (Ghana/West Africa operations): Global pharmaceutical multinational with established Ghana and West African distribution for branded and generic specialty products; competes in the same hospital and pharmacy channels but with much deeper R&D pipeline and capital base.

Regional players

• Eva Pharma: Egypt-based pharmaceutical manufacturer with growing African footprint in generics (including antimalarials and antibiotics); comparable in therapeutic focus and Africa-export model but does not yet have on-the-ground Ghana distribution of Tobinco's scale.
• Adcock Ingram Holdings Limited: South Africa-based manufacturer and distributor of prescription, OTC and consumer health products with selective expansion into Sub-Saharan Africa; overlaps in therapeutic categories (analgesics, cough & cold, vitamins) and pharmacy-channel distribution but is primarily South African in footprint.

Others

• mPedigree Network: Ghana-headquartered anti-counterfeiting and pharmaceutical supply-chain verification provider; not a direct competitor but an enabling partner/ecosystem player whose Goldkeys and Sproxil services are directly relevant to the regulatory and supply-chain integrity risks Tobinco has faced.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Tobincopharmacy
• Facebookfacebook.com/profile.php
• Instagraminstagram.com/tobincopharma
• LinkedInlinkedin.com/company/tobinco-pharmaceuticals-limited

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tobinco Pharmaceuticals